Tag: Adagrasib

Adagrasib safe and clinically active in non-small cell lung cancer

Presented By
Dr Alexander Spira, Virginia Cancer Specialists Research Institute, VA, USA
Trial
Phase 2, KRYSTAL-1
Conference
ASCO 2022
Type
Peer-reviewed article

5 August 2022 12:33

Adagrasib shows promising clinical activity in heavily pretreated KRAS-mutated CRC

Presented By
Dr Jared Weiss, University of North Carolina at Chapel Hill, NC, USA
Trial
Phase 1/2, KRYSTAL-1
Conference
ESMO 2021
Type
Peer-reviewed article

19 November 2021 09:42
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com